Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 8 min read

This article was created with AI assistance.

Purpura Fulminans for ICU Nurses 2026 — When the Skin and Limbs Clot and Die

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Emergencies Hub — browse every related guide in one place.

A septic patient develops dark purple patches on the skin that, over hours, spread and turn from bruise to blister to black. Fingers and toes go dusky and cold. The blood work shows a consumed clotting system — low platelets, low fibrinogen, a soaring D-dimer — and the patient is oozing from every puncture site while, paradoxically, clotting off the tiny vessels that feed the skin. This is purpura fulminans, one of the most dramatic and dangerous manifestations of severe sepsis and disseminated intravascular coagulation, and it can cost a patient their limbs or their life within a day.

The short version: Purpura fulminans is a rapidly progressive skin necrosis caused by widespread clotting in the small vessels (microvascular thrombosis), usually in the setting of severe sepsis and DIC. Blood clots block the tiny vessels supplying the skin and extremities, so the tissue dies — producing spreading purple-black lesions, hemorrhagic blisters, and gangrene of the digits or limbs — even as the consumption of clotting factors leaves the patient bleeding elsewhere. The classic trigger is meningococcemia (and other overwhelming bacterial infections), and it is also seen with severe protein C/S deficiency. It is a marker of critical illness with high mortality and limb loss. Treatment is aggressive treatment of the underlying infection and shock, DIC support, and meticulous tissue and limb care.

The paradox: clotting and bleeding at once

Purpura fulminans is the visible face of a coagulation system that has turned on itself. In severe sepsis, the same inflammatory storm that drops the blood pressure also flips the blood into a pro-clotting state, and natural anticoagulant pathways (notably protein C) are depleted. Tiny clots form throughout the microcirculation, and where those clots choke off the vessels feeding the skin, the tissue dies — that is the spreading purpura and, at the extremities, frank gangrene. At the very same time, all that clotting consumes platelets and clotting factors faster than the body can replace them, so the patient bleeds from IV sites, mucous membranes, and wounds. This is why the lab picture is that of DIC: low platelets, low fibrinogen, prolonged clotting times, and a high D-dimer. Understanding both halves of the paradox explains why care has to support clotting factors while the root cause — usually overwhelming infection — is attacked.

Recognizing and staging the skin

Stage / findingWhat it means
Early erythema or dusky patchesBeginning microvascular compromise — act early
Well-demarcated purple (purpuric) lesionsSkin infarction from small-vessel thrombosis
Hemorrhagic bullae (blood blisters)Advancing necrosis
Black, hard eschar; cold dusky digitsEstablished gangrene — risk of limb loss
Oozing from lines, gums, woundsConsumptive coagulopathy (DIC)
Shock, fever, altered mentationUnderlying severe sepsis — the driver

Serial mapping of the lesions matters: photographing and marking the borders lets the team see how fast the necrosis is advancing and how tissue is responding to resuscitation. Because meningococcemia is a classic cause and can spread from a petechial rash to fulminant purpura in hours, a rapidly evolving purpuric rash in a febrile, ill patient is a call-the-team-now finding, not something to reassess at the next round.

The priorities are the same as for the sepsis behind it

Purpura fulminans is a skin manifestation of a whole-body emergency — treat the cause fast. The single most important interventions are the ones aimed at the underlying process: early broad-spectrum antibiotics (do not delay for procedures if meningococcemia or another aggressive infection is suspected — and remember close contacts of meningococcal disease may need prophylaxis), aggressive resuscitation of septic shock with fluids and vasopressors as needed, and source control. Alongside that, DIC is supported per the bleeding and lab picture — platelets, fresh frozen plasma, and fibrinogen replacement (cryoprecipitate) are guided by active bleeding and trends rather than by numbers alone. Isolation precautions may be needed until an organism like meningococcus is excluded or covered.

The skin and limbs need dedicated attention too. Threatened extremities are monitored closely for perfusion, and the team weighs the risk of compartment syndrome and the eventual need for debridement or amputation of nonviable tissue — decisions usually deferred until the acute storm settles and the line between dead and salvageable tissue declares itself. Anticoagulation and specific factor replacement (such as protein C concentrate in certain deficiencies) are considered in select cases by the intensive care and hematology teams.

The nurse's role

Nursing care runs on several tracks at once. For the sepsis: rapid antibiotic administration, fluid and vasopressor titration, and continuous monitoring of perfusion, urine output, mentation, and hemodynamics. For the coagulopathy: watching for bleeding at every site, minimizing unnecessary punctures and applying prolonged pressure when they are needed, and administering blood products per protocol while monitoring for transfusion reactions. For the skin and limbs: gentle handling of fragile, necrotic tissue, careful positioning and pressure offloading to avoid worsening ischemia, serial neurovascular checks of threatened extremities, wound care per the plan, and documentation (including photographs) of lesion progression. Pain from ischemic tissue is significant and needs proactive management. Throughout, the family is facing a patient who may lose fingers, limbs, or their life very quickly — honest, compassionate updates and early involvement of the care team in goals-of-care conversations are part of good nursing.

Bottom line: Purpura fulminans is rapidly spreading skin and limb necrosis from microvascular clotting, almost always driven by severe sepsis and DIC and classically by meningococcemia. The blood clots off the vessels feeding the skin while consuming clotting factors, so the patient infarcts and bleeds at the same time. Survival and limb salvage hinge on treating the underlying infection and shock immediately, supporting the coagulopathy, and providing meticulous tissue, perfusion, and comfort care.

Related reading

Explore related ICU sepsis and coagulation emergencies: disseminated intravascular coagulation (DIC), septic shock, Waterhouse-Friderichsen syndrome, and massive transfusion protocol.

Get the ICU Notebook

Free investing strategies built for nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.